Proficio Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-327
| Closed | -$207K | – | 467 |
|
|
2025
Q1 | $207K | Buy |
327
+19
| +6% | +$12.1K | 0.02% | 367 |
|
|
2024
Q4 | $219K | Buy |
308
+72
| +31% | +$51.3K | 0.02% | 327 |
|
|
2024
Q3 | $248K | Sell |
236
-66
| -22% | -$69.4K | 0.02% | 243 |
|
|
2024
Q2 | $317K | Sell |
302
-2
| -0.7% | -$2.1K | 0.03% | 241 |
|
|
2024
Q1 | $293K | Buy |
304
+16
| +6% | +$15.4K | 0.03% | 251 |
|
|
2023
Q4 | $253K | Sell |
288
-66
| -19% | -$58K | 0.03% | 254 |
|
|
2023
Q3 | $291K | Buy |
354
+8
| +2% | +$6.58K | 0.04% | 221 |
|
|
2023
Q2 | $249K | Sell |
346
-29
| -8% | -$20.8K | 0.03% | 246 |
|
|
2023
Q1 | $308K | Buy |
+375
| New | +$308K | 0.05% | 203 |
|
|
2022
Q1 | – | Sell |
-318
| Closed | -$201K | – | 324 |
|
|
2021
Q4 | $201K | Buy |
+318
| New | +$201K | 0.03% | 296 |
|
|
2019
Q3 | – | Sell |
-274
| Closed | -$86K | – | 1208 |
|
|
2019
Q2 | $86K | Buy |
274
+30
| +12% | +$9.42K | 0.03% | 237 |
|
|
2019
Q1 | $100K | Buy |
244
+31
| +15% | +$12.7K | 0.04% | 199 |
|
|
2018
Q4 | $80K | Buy |
213
+1
| +0.5% | +$376 | 0.04% | 197 |
|
|
2018
Q3 | $86K | Buy |
212
+6
| +3% | +$2.43K | 0.03% | 225 |
|
|
2018
Q2 | $71K | Sell |
206
-13
| -6% | -$4.48K | 0.03% | 266 |
|
|
2018
Q1 | $75K | Sell |
219
-37
| -14% | -$12.7K | 0.02% | 257 |
|
|
2017
Q4 | $96K | Sell |
256
-360
| -58% | -$135K | 0.03% | 211 |
|
|
2017
Q3 | $275K | Sell |
616
-34
| -5% | -$15.2K | 0.11% | 116 |
|
|
2017
Q2 | $310K | Sell |
650
-6
| -0.9% | -$2.86K | 0.13% | 110 |
|
|
2017
Q1 | $301K | Buy |
656
+393
| +149% | +$180K | 0.13% | 111 |
|
|
2016
Q4 | $97K | Buy |
263
+120
| +84% | +$44.3K | 0.04% | 185 |
|
|
2016
Q3 | $57K | Buy |
143
+24
| +20% | +$9.57K | 0.03% | 249 |
|
|
2016
Q2 | $49K | Sell |
119
-2
| -2% | -$824 | 0.03% | 275 |
|
|
2016
Q1 | $44K | Buy |
121
+108
| +831% | +$39.3K | 0.04% | 231 |
|
|
2015
Q4 | $7K | Buy |
+13
| New | +$7K | 0.01% | 349 |
|